Page 3 - Asaf Zviran News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Asaf zviran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Asaf Zviran Today - Breaking & Trending Today

A blood test that can identify recurrent cancer

A new genomic platform uses AI to enable doctors to find mutations signifying persistent or recurrent cancer cells months or years before current technologies. ....

New York , United States , Israel General , United Kingdom , Shaare Zedek , Asaf Zviran , Boris Oklander , Idan Landau , York Genome Center , Weizmann Institute Of Science , Duquesne Family Office , Israel Institute Of Technology , Shaare Zedek Medical Center , Technion Israel Institute , Weizmann Institute , New York Genome Center , Weill Cornell Medicine , Casdin Capital , Globe Partners , Driehaus Capital , Margalit Startup City , C2i Genomics ,

Israeli Breakthrough: Blood Test Can Identify Recurrent Cancer

Israeli Breakthrough: Blood Test Can Identify Recurrent Cancer
unitedwithisrael.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from unitedwithisrael.org Daily Mail and Mail on Sunday newspapers.

New York , United States , Israel General , United Kingdom , Abigail Klein Leichman , Shaare Zedek , Asaf Zviran , Boris Oklander , Idan Landau , York Genome Center , Weizmann Institute Of Science , Duquesne Family Office , Israel Institute Of Technology , Shaare Zedek Medical Center , Technion Israel Institute , Weizmann Institute , New York Genome Center , Weill Cornell Medicine , Casdin Capital , Globe Partners , Driehaus Capital , Margalit Startup City , Show Your ,

Cancer detection tech uses AI, whole-genome sequencing

Cancer detection tech uses AI, whole-genome sequencing
An advanced cancer detection platform from C2i Genomics (reportedly capable of spotting miniscule traces of the disease) recently landed $100m in funding.
Cancer intelligence company recently received $100m in funding to help accelerate the development and commercialization of its Intelligence Platform. The cancer diagnostics technology uses artificial intelligence (AI) pattern recognition paired with whole-genome analysis to achieve rapid, accurate detection of residual disease; according to the company, the technology is up to 100 times more sensitive than similar technologies.
Asaf Zviran, co-founder and CEO of C2i Genomics, spoke with Outsourcing-Pharma about the technology, plans for the future, and how his experience as a cancer survivor helped inform its development. ....

United States , Asaf Zviran , Dan Landau At Cornell University , Langone Health , National Cancer Center , Aarhus University Hospital , Lausanne University Hospital , Hospital Of The University Pennsylvania , York University Langone Medical Center , New York University , Langone Medical Center , Idan Landau , Cornell University , ஒன்றுபட்டது மாநிலங்களில் , லன்கொனே ஆரோக்கியம் , தேசிய புற்றுநோய் மையம் , ஆர்ஹஸ் பல்கலைக்கழகம் மருத்துவமனை , மருத்துவமனை ஆஃப் தி பல்கலைக்கழகம் பென்சில்வேனியா , யார்க் பல்கலைக்கழகம் லன்கொனே மருத்துவ மையம் , புதியது யார்க் பல்கலைக்கழகம் , லன்கொனே மருத்துவ மையம் , டான் ல்யாந்‌டா , கார்னெல் பல்கலைக்கழகம் ,

A cancer survivor raised $100M for his startup to detect the disease earlier

Results for
A cancer survivor raised $100M for his startup to detect the disease earlier
Israeli MedTech startup C2i Genomics can detect the smallest cancer residual, empowering both patient and doctor with early detection like never before
Oshry Alkeslasi
/
19 Apr 2021
•
2 min read
With more and more technology and medical info, cancer diagnostics has received significant upgrades over the years. However, even after the cancerous tumors had been removed, there often remains a tiny amount of hazardous cells which cannot be identified by current practices. An Israeli startup has developed a platform to solve this very problem, and has raised $100 million to get it done. ....

New York , United States , United Kingdom , Cornell University , Asaf Zviran , Boris Oklander , Ezra Sofer , Langone Health , York Genome Center , Singapore Cancer Research Center , Lausanne University Faculty Of Biology , Duquense Family Office , Aarhus Medical College , Genomic Saas , New York Genome Center , Cancer Research Center , Lausanne University , Casdin Capital , Gigi Levy Weiss , Globe Partners , Driehaus Capital , Duquense Family , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , கார்னெல் பல்கலைக்கழகம் ,

Cancer surveillance co C2i Genomics raises $100m

Cancer surveillance co C2i Genomics raises $100m
The company s cancer diagnostics service uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease.
Cancer surveillance company C2i Genomics has announced the completion of a $100 million financing round led by Casdin Capital with participation from NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others.
The funding will accelerate clinical development and commercialization of the company’s C2-Intelligence Platform, a cancer diagnostics service that uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease that is up to 100 times more sensitive than competing technologies. ....

Asaf Zviran , Langone Health , Aarhus University Hospital , Lausanne University Hospital , Duquesne Family Office , National Cancer Centre Singapore , Casdin Capital , Globe Partners , Driehaus Capital , Intelligence Platform , லன்கொனே ஆரோக்கியம் , ஆர்ஹஸ் பல்கலைக்கழகம் மருத்துவமனை , ட்யூக்வ்ஸ்ந் குடும்பம் அலுவலகம் , தேசிய புற்றுநோய் மையம் சிங்கப்பூர் , பூகோளம் கூட்டாளர்கள் , உளவுத்துறை நடைமேடை ,